Recent advances in claudin-targeting technology.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1248/BPB.B13-00014PMID 23649330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of the ‘angulin’ proteins LSR, ILDR1 and ILDR2 – tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis

  2013cited by this paper
• Creation and biochemical analysis of a broad-specific claudin binder.

  2012cited by this paper
• Transient opening of the perineurial barrier for analgesic drug delivery

  2012cited by this paper
• LSR defines cell corners for tricellular tight junction formation in epithelial cells

  2011cited by this paper
• A toxicological evaluation of a claudin modulator, the C-terminal fragment of Clostridium perfringens enterotoxin, in mice.

  2011cited by this paper
• Mucosal vaccination using claudin-4-targeting.

  2010cited by this paper
• Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.

  2010cited by this paper
• A Claudin-Targeting Molecule as an Inhibitor of Tumor Metastasis

  2010cited by this paper
• A Novel Screening System for Claudin Binder Using Baculoviral Display

  2010cited by this paper
• A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide.

  2010cited by this paper
• Therapeutic antitumor efficacy of monoclonal antibody against Claudin‐4 for pancreatic and ovarian cancers

  2009cited by this paper
• Clostridium perfringens Enterotoxin Interacts with Claudins via Electrostatic Attraction*

  2009cited by this paper
• HPV vaccine for all.

  2009cited by this paper
• A Novel Tumor-Targeted Therapy Using a Claudin-4-Targeting Molecule

  2009cited by this paper
• Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: A novel model for studying the pathomechanisms of inflammatory bowel disease cytokines

  2009cited by this paper
• Functional reconstitution of G-protein-coupled receptor-mediated adenylyl cyclase activation by a baculoviral co-display system.

  2008cited by this paper
• Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis.

  2008cited by this paper
• Structural Constraints for the Binding of Short Peptides to Claudin-4 Revealed by Surface Plasmon Resonance

  2008cited by this paper
• Immunological commonalities and distinctions between airway and digestive immunity.

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Cell polarity in development and cancer

  2007cited by this paper
• Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

  2007cited by this paper
• Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis.

  2007cited by this paper
• Preparation of a Claudin-Targeting Molecule Using a C-Terminal Fragment of Clostridium perfringens Enterotoxin

  2006cited by this paper
• Claudins: emerging targets for cancer therapy

  2006cited by this paper
• Immunotoxins in the treatment of hematologic malignancies.

  2006cited by this paper
• Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells

  2005cited by this paper
• Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4.

  2005cited by this paper
• Claudin proteins in human cancer: promising new targets for diagnosis and therapy.

  2005cited by this paper
• Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.

  2005cited by this paper
• Mucosa-associated lymphoid tissues in the aerodigestive tract: their shared and divergent traits and their importance to the orchestration of the mucosal immune system.

  2005cited by this paper
• A Novel Strategy for the Enhancement of Drug Absorption Using a Claudin Modulator

  2005cited by this paper
• NALT- versus PEYER'S-patch-mediated mucosal immunity

  2004cited by this paper
• The tight junction: a multifunctional complex.

  2004cited by this paper
• Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice

  2003cited by this paper
• Characteristics of Claudin Expression in Follicle-Associated Epithelium of Peyer's Patches: Preferential Localization of Claudin-4 at the Apex of the Dome Region

  2003cited by this paper
• Claudin-based tight junctions are crucial for the mammalian epidermal barrier

  2002cited by this paper
• Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

  2001cited by this paper
• Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.

  1999cited by this paper
• Strategies for mucosal vaccine development.

  1999cited by this paper
• New approaches to mucosal immunization.

  1999cited by this paper
• Recovery of homogeneous and functional β2-adrenergic receptors from extracellular baculovirus particles

  1997cited by this paper
• A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.

  1997cited by this paper
• New approaches to mucosal immunization.

  1996cited by this paper
• The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications

  1995cited by this paper
• Ultrastructural and cytoarchitectural features of lymphoreticular organs in the colon and rectum of adult BALB/c mice.

  1991cited by this paper
• Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Barrier function of epithelia.

  1981cited by this paper
• Gastro-Intestinal Absorption of Heparin and Synthetic Heparinoids

  1961cited by this paper

• Claudins in ovarian cancer: emerging biomarkers and therapeutic targets

  2025cites this paper
• Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting

  2019cites this paper
• Specific binding of a mutated fragment of Clostridium perfringens enterotoxin to endothelial claudin-5 and its modulation of cerebral vascular permeability.

  2016influential citation
• Efficacy and safety evaluation of claudin‐4‐targeted antitumor therapy using a human and mouse cross‐reactive monoclonal antibody

  2016cites this paper
• Systems Proteomics View of the Endogenous Human Claudin Protein Family.

  2016cites this paper
• Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders.

  2015cites this paper
• Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies

  2015cites this paper
• [Claudin 1 as a target for anti-hepatitis C virus strategy].

  2014cites this paper